These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12354527)

  • 1. Immunohistochemical detection of melanoma-specific antigens in spontaneous canine melanoma.
    Sulaimon S; Kitchell B; Ehrhart E
    J Comp Pathol; 2002; 127(2-3):162-8. PubMed ID: 12354527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen expression in canine tissues, recognized by a monoclonal antibody generated against canine melanoma cells.
    Oliver JL; Wolfe LG
    Am J Vet Res; 1992 Jan; 53(1):123-8. PubMed ID: 1539903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical investigation of PNL2 reactivity of canine melanocytic neoplasms and comparison with Melan A.
    Giudice C; Ceciliani F; Rondena M; Stefanello D; Grieco V
    J Vet Diagn Invest; 2010 May; 22(3):389-94. PubMed ID: 20453212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine balloon and signet-ring cell melanomas: a histological and immunohistochemical characterization.
    Cangul IT; van Garderen E; van der Linde-Sipman JS; van den Ingh TS; Schalken JA
    J Comp Pathol; 2001; 125(2-3):166-73. PubMed ID: 11578133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis.
    Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C
    Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors.
    Steuhl KP; Rohrbach JM; Knorr M; Thiel HJ
    Ophthalmology; 1993 Feb; 100(2):208-15. PubMed ID: 8437829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of prognostic significance of angiogenesis in canine melanocytic tumours.
    Cuitiño MC; Massone AR; Idiart JR
    J Comp Pathol; 2012; 147(2-3):147-52. PubMed ID: 22520819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
    Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
    J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of melanoma-associated antigens on formalin-fixed, paraffin-embedded canine tumors.
    Berrington AJ; Jimbow K; Haines DM
    Vet Pathol; 1994 Jul; 31(4):455-61. PubMed ID: 7941235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors.
    Wick MR; Swanson PE; Rocamora A
    J Cutan Pathol; 1988 Aug; 15(4):201-7. PubMed ID: 3053811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
    Mirecka J; Korabiowska M; Schauer A
    Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostaining of human melanomas by a monoclonal antibody to B700 mouse melanoma antigen.
    Xu X; Azumi N; Skelton HG; Hearing VJ; Gersten DM
    Eur J Cancer; 1996 Jan; 32A(1):168-73. PubMed ID: 8695227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45.
    Heegaard S; Jensen OA; Prause JU
    Melanoma Res; 2000 Aug; 10(4):350-4. PubMed ID: 10985669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.
    Jungbluth AA; Busam KJ; Gerald WL; Stockert E; Coplan KA; Iversen K; MacGregor DP; Old LJ; Chen YT
    Am J Surg Pathol; 1998 May; 22(5):595-602. PubMed ID: 9591730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical studies of conjunctival nevi and melanomas.
    Jakobiec FA; Bhat P; Colby KA
    Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections.
    Imam A; Mitchell MS; Modlin RL; Taylor CR; Kempf RA; Kan-Mitchell J
    J Invest Dermatol; 1986 Feb; 86(2):145-8. PubMed ID: 3528308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
    Zubovits J; Buzney E; Yu L; Duncan LM
    Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of tenascin in melanocytic tumours of dogs.
    Sevastre B; van Ederen AM; Terlou M; Gruys E; Nederbragt H
    J Comp Pathol; 2007 Jan; 136(1):49-56. PubMed ID: 17258226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral melanocytic lesions: differences in expression of HMB-45 and S-100 antigens in round and spindle cells of malignant and benign lesions.
    Gazit D; Daniels TE
    J Oral Pathol Med; 1994 Feb; 23(2):60-4. PubMed ID: 8164154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MAGE--A restricted to testis and ovary or to various cancers in dogs.
    Chen YC; Hsu WL; Chiu CY; Liao JW; Chang CC; Chang SC
    Vet Immunol Immunopathol; 2013 May; 153(1-2):26-34. PubMed ID: 23466080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.